A B S T R A CT The effect of high doses of 25-hydroxycholecalciferol on plasma calcium concentration was studied in rats receiving a low-calcium normal vitamin D diet. In bilaterally nephrectomized animals, as in shamoperated controls, 62.5 nmol of 25-hyroxycholecalciferol did not produce a rise of plasma calcium concentration. In contrast, the administration of 125 or 625 nmol, doses 1,000-5,000 times the minimal active dose in D-deficient rats, was followed in both groups of animals by a significant increase of plasma calcium concentration. Removal of either parathyroids alone or parathyroid and thyroid glands did not suppress this effect. These data suggest that when large doses are used in vivo, the renal conversion of 25-hydroxycholecalciferol to more polar metabolites is not an obligatory step for its calciummobilizing action. The present study does not elucidate, however, the exact mechanism(s) of this effect.
INTRODUCTION
25-hydroxycholecalciferol (25-(OH)-D3)' was isolated, identified, and synthesized by Lund and DeLuca, Blunt, DeLuca, and Schnoes, and DeLuca (1) (2) (3) . More recently it has been demonstrated that this metabolite, the major Received for publication 17 circulating form of vitamin D, becomes biologically active only if converted to more polar substances (4) (5) (6) (7) . The currently available in vivo data indicate that the kidney is the only organ able to convert 25-(OH)-D3 to 1,25-dihydroxycholecalciferol (1, 25 -(OH)2-D8), 24,25-dihydroxycholecalciferol, and other metabolites (8) (9) (10) . Furthermore it is well established that as much as 62.5 nmol of 25-(OH)-D3 will not produce the characteristic bone calcium mobilization effect in D-deficient rats if the kidneys ars removed (11, 12 ). Yet in vitro organ culture studies (13) (14) and our clinical results (15) are not in complete agreement with these conclusions. In fact, a calcium-mobilizing effect of 25-(OH)-D3 has been observed in bone tissue cultures when high concentrations of 25-(OH)-D3 were added to the medium (13) (14) ; and we have seen that large doses of 25-(OH)-D8 are highly active on bones of severely uremic children with glomerular filtration rates less than 10 ml/min/1.73 m2 (15 Experimental animals and protocol. Weanling 21-day-old male albino Wistar rats were used for all experiments (Sodelabo, Conde s/Huisne, France). They were given food and deionised drinking water ad libitum. The synthetic diet (17) containing 0.47%c calcium and 30% phosphorus was supplemented daily with adequate amounts of fat-soluble vitamins. After 5 days on this diet animals were randomly divided into three groups. Rats from the first group had their parathyroids destroyed by hot-wire cautery (PTX), those from the second group were surgically thyroparathyroidectomized (TPTX), and the animals of the third group, sham-operated, had their tracheas exposed. After surgery the animals were fed a low-calcium diet (18) containing 0.02% calcium and 0.30%o phosphorus for 3 days.
At this time plasma calcium concentration was determined in samples obtained by tail incision. In control animals it was 9.1±0.2 mg/100 ml. In the group of PTX and TPTX animals only those with a plasma calcium concentration less than 6 mg/100 ml were considered successfully operated and used in the study. Then, in sham-operated and PTX groups, half the animals were bilaterally nephrectomized, and the others had exploration of the renal area. Imme In the non-PTX rats, 24 h after kidney ablation a significant rise of plasma calcium concentration (P < 0.001) is observed in untreated animals. This hypercalcemic effect of bilateral nephrectomy, already reported by Jastak, Morrison, and Raisz (21) and Delorme, Cuisinier-Gleizes, Dulac, and Mathieu (22) in non-vitamin D-deficient rats, is generally attributed to increased secretion of parathyroid hormone after kidney ablation. In fact, this rise of plasma calcium is abolished in previously PTX rats. In nephrectomized animals, as in nonnephrectomized ones, changes of plasma calcium concentration observed after intrajugular injection of 62.5 nmol of 25-(OH)-Ds are not different from those observed in untreated animals. But 125 nmol produces a significant rise of serum calcium concentration (P < 0.001 in both non-PTX and PTX animals); this response is also significantly (P < 0.01) more pronounced after administration of 625 nmol of 25-(OH)-Da. Thus, in nephrectomized, as in unnephrectomized rats, the presence or the absence of the parathyroid glands does not significantly change the calcium-mobilizing action of the different doses of 25-(OH)-D3. (12, 20) . The present results also show that this action is not parathyroid-or thyroid-dependent, since it is not suppressed by removal of these glands. Moreover it indicates that this action is not modified by the basic level of plasma calcium concentration, as it occurs in sham-operated animals with a plasma calcium of 9.0±0.1, and in PTX or TPTX animals with a plasma calcium concentration, respectively, of 5.1±0.1 and 5.6±0.1. Yet the importance of these parameters for the further metabolism of 25-(OH)-D3, though contested by Shain (24) , has been suggested by several in vivo and in vitro experiments (25) (26) (27) (28) (29) .
DISCUSSION
Although the present study does not elucidate the exact mechanism(s) by which high doses of 25-(OH)-D;.
are active in anephric animals, it does show conclusively that: (a) renal conversion of this metabolite is not an obligatory step in the calcium-mobilizing action of such doses; and (b) this biological activity, either a direct effect of 25-(OH)-D3 itself or a secondary effect of the extrarenal formation of a presently unidentified metabolite, does not require the presence of the parathyroid or thyroid gland and is not modified by extracellular concentration of calcium.
